2nd Quarter - Report

WEST FRONT STRATEGIES LLC for VIATRIS INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Issues related to the antitrust review of Teva Pharmaceuticals Industries, Ltd. offer to acquire Mylan N.V.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Issues related to the intellectual property provisions in the Trans-Pacific Partnership negotiations.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Issues related to corporate tax reform.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Issues related to patent litigation reform, including H.R. 9, the Innovation Act; S. 632, the STRONG Patents Act; and S. 1137, the PATENT Act.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 632 (114th), S. 1137 (114th), H.R. 9 (114th)

Health Issues HCR

Issues related to implementation of the Generic Drug User Fee Agreement; Issues related to H.R. 6, 21st Century Cures Initiative and Senate HELP Innovation Initiative; FDA proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; FDA proposed rule, Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products; Issues related to generic drug pricing.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Budget/Appropriations BUD

FY 2016 Agriculture/FDA Appropriations, in particular, FDA funding and sequestration of user fees; FY 2016 State/Foreign Operations Appropriations, in particular, PEPFAR funding.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.